Aktis Oncology, Inc. (AKTS) NASDAQ
20.26
+0.78(+4.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.18B |
| Enterprise Value | 1.15B |
| P/E Ratio | -24.6 |
| PEG Ratio | -0.25 |
| Price/Sales Ratio | 179.43 |
| Price/Book Ratio | 2.21 |
| Enterprise/Revenue | 119.72 |
| Enterprise/EBITDA | -13.39 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -7.55 |
| Operating Margin | -9.24 |
Management Effectiveness
| Return On Assets | -0.08 |
| Return On Equity | -1.3 |
Income Statement
| Revenue | 6.5M |
| Revenue/Share | 0.11 |
| Gross Profit | 6.5M |
| EBITDA | -72.36M |
| Net Income | -63.73M |
| Diluted EPS | -1.19 |
Balance Sheet
| Total Cash | 538.48M |
| Total Cash/Share | 9.74 |
| Total Debt | 11.58M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 19.49 |
| Book Value Per Share | 9.16 |
Price History
| 52-Week Change | -9.55 |
| 52-Week High | 29.16 |
| 52-Week Low | 14.72 |
| Moving Average 50 Days | 18.91 |
| Moving Average 200 Days | 19.3 |
Statistics
| Average Volume | 321,107 |
| Shares Outstanding | 53.4M |
| % Held by Institutions | 62.8 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
